• Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, Bray F. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. Cancer J Clin. 2021;71(3):209-49.

  • Jess T, Rungoe C, Peyrin-Biroulet L. Risk of colorectal cancer in patients with ulcerative colitis: a meta-analysis of population-based cohort studies. Clin Gastroenterol Hepatol. 2012;10(6):639–45.

    Article 

    Google Scholar
     

  • Laukoetter MG, Mennigen R, Hannig CM, Osada N, Rijcken E, Vowinkel T, Krieglstein CF, Senninger N, Anthoni C, Bruewer M. Intestinal cancer risk in Crohn’s disease: a meta-analysis. J Gastrointestinal Surg. 2011;15(4):576–583.

  • Chan AT, Giovannucci EL, Meyerhardt JA, Schernhammer ES, Curhan GC, Fuchs CS. Long-term use of aspirin and nonsteroidal anti-inflammatory drugs and risk of colorectal cancer. Jama. 2005;294(8):914–23.

    CAS 
    Article 

    Google Scholar
     

  • Cole BF, Logan RF, Halabi S, Benamouzig R, Sandler RS, Grainge MJ, Chaussade S, Baron JA. Aspirin for the chemoprevention of colorectal adenomas: meta-analysis of the randomized trials. J Natl Cancer Institute. 2009;101(4):256–66.

    CAS 
    Article 

    Google Scholar
     

  • Coussens LM, Werb Z. Inflammation and cancer. Nature. 2002;420(6917):860–7.

    CAS 
    Article 

    Google Scholar
     

  • Pendyala S, Neff LM, Suarez-Farinas M, Holt PR. Diet-induced weight loss reduces colorectal inflammation: implications for colorectal carcinogenesis. Am J Clin Nutr. 2011;93(2):234–42.

    CAS 
    Article 

    Google Scholar
     

  • Zhou B, Shu B, Yang J, Liu J, Xi T, Xing Y. C-reactive protein, interleukin-6 and the risk of colorectal cancer: a meta-analysis. Cancer Causes Control. 2014;25(10):1397–405.

    Article 

    Google Scholar
     

  • Boden S, Myte R, Harbs J, Sundkvist A, Zingmark C, Lofgren Burstrom A, Palmqvist R, Harlid S, Van Guelpen B. C-reactive protein and future risk of clinical and molecular subtypes of colorectal cancer. Cancer Epidemiol Biomarkers Prev. 2020;29(7):1482-91.

  • Aleksandrova K, Jenab M, Boeing H, Jansen E, Bueno-de-Mesquita HB, Rinaldi S, Riboli E, Overvad K, Dahm CC, Olsen A, et al. Circulating C-reactive protein concentrations and risks of colon and rectal cancer: a nested case-control study within the European Prospective Investigation into Cancer and Nutrition. Am J Epidemiol. 2010;172(4):407–18.

    Article 

    Google Scholar
     

  • Nimptsch K, Aleksandrova K, Boeing H, Janke J, Lee YA, Jenab M, Bueno-de-Mesquita HB, Jansen EH, Tsilidis KK, Trichopoulou A, et al. Association of CRP genetic variants with blood concentrations of C-reactive protein and colorectal cancer risk. Int J Cancer. 2015;136(5):1181–92.

    CAS 
    Article 

    Google Scholar
     

  • Wang X, Dai JY, Albanes D, Arndt V, Berndt SI, Bezieau S, Brenner H, Buchanan DD, Butterbach K, Caan B, et al. Mendelian randomization analysis of C-reactive protein on colorectal cancer risk. Int J Epidemiol. 2019;48(3):767–80.

    Article 

    Google Scholar
     

  • Jung SY, Yu H, Pellegrini M, Papp JC, Sobel EM, Zhang ZF. Genetically determined elevated C-reactive protein associated with primary colorectal cancer risk: Mendelian randomization with lifestyle interactions. Am J Cancer Res. 2021;11(4):1733–53.

    CAS 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Pathak S, Nunes QM, Daniels IR, Smart NJ. Is C-reactive protein useful in prognostication for colorectal cancer? A systematic review. Colorectal Dis. 2014;16(10):769–76.

    CAS 
    Article 

    Google Scholar
     

  • Roxburgh CS, Salmond JM, Horgan PG, Oien KA, McMillan DC. The relationship between the local and systemic inflammatory responses and survival in patients undergoing curative surgery for colon and rectal cancers. J Gastrointestinal Surg. 2009;13(11):2011–8 discussion 2018–2019.

    Article 

    Google Scholar
     

  • Tuomisto AE, Makinen MJ, Vayrynen JP. Systemic inflammation in colorectal cancer: Underlying factors, effects, and prognostic significance. World J Gastroenterol. 2019;25(31):4383–404.

    CAS 
    Article 

    Google Scholar
     

  • Ghuman S, Van Hemelrijck M, Garmo H, Holmberg L, Malmstrom H, Lambe M, Hammar N, Walldius G, Jungner I, Wulaningsih W. Serum inflammatory markers and colorectal cancer risk and survival. Brit J Cancer. 2017;116(10):1358–65.

    CAS 
    Article 

    Google Scholar
     

  • Allin KH, Bojesen SE, Nordestgaard BG. Baseline C-reactive protein is associated with incident cancer and survival in patients with cancer. J Clin Oncol. 2009;27(13):2217–24.

    CAS 
    Article 

    Google Scholar
     

  • Slattery ML, Curtin K, Poole EM, Duggan DJ, Samowitz WS, Peters U, Caan BJ, Potter JD, Ulrich CM. Genetic variation in C-reactive protein in relation to colon and rectal cancer risk and survival. Int J Cancer. 2011;128(11):2726–34.

    CAS 
    Article 

    Google Scholar
     

  • Yang SH, Huang CJ, Chang SC, Lin JK. Association of C-reactive protein gene polymorphisms and colorectal cancer. Ann Surg Oncol. 2011;18(7):1907–15.

    Article 

    Google Scholar
     

  • Hua X, Dai JY, Lindstrom S, Harrison TA, Lin Y, Alberts SR, Alwers E, Berndt SI, Brenner H, Buchanan DD, et al. Genetically predicted circulating C-reactive protein concentration and colorectal cancer survival: A Mendelian randomization consortium study. Cancer Epidemiol Biomarkers Prev. 2021;30(7):1349-58.

  • Riboli E, Hunt KJ, Slimani N, Ferrari P, Norat T, Fahey M, Charrondiere UR, Hemon B, Casagrande C, Vignat J, et al. European Prospective Investigation into Cancer and Nutrition (EPIC): study populations and data collection. Public Health Nutr. 2002;5(6B):1113–24.

    CAS 
    Article 

    Google Scholar
     

  • Bingham S, Riboli E. Diet and cancer–the European Prospective Investigation into Cancer and Nutrition. Nat Rev Cancer. 2004;4(3):206–215.

  • Riboli E, Kaaks R. The EPIC Project: rationale and study design. European Prospective Investigation into Cancer and Nutrition. International journal of epidemiology. 1997;26(Suppl 1):S6-14.

    PubMed 

    Google Scholar
     

  • Jenab M, Bueno-de-Mesquita HB, Ferrari P, van Duijnhoven FJ, Norat T, Pischon T, Jansen EH, Slimani N, Byrnes G, Rinaldi S, et al. Association between pre-diagnostic circulating vitamin D concentration and risk of colorectal cancer in European populations:a nested case-control study. BMJ (Clinical research ed). 2010;340:b5500.

    Article 

    Google Scholar
     

  • Benjamin EJ, Dupuis J, Larson MG, Lunetta KL, Booth SL, Govindaraju DR, Kathiresan S, Keaney JF Jr., Keyes MJ, Lin JP, et al. Genome-wide association with select biomarker traits in the Framingham Heart Study. BMC Med Genet. 2007;8(Suppl 1):S11.

    Article 

    Google Scholar
     

  • Hosmer DW, Lemeshow S. Applied survival analysis: regression modeling of time to event data. New York: Wiley; 1999.


    Google Scholar
     

  • Lin X, Song K, Lim N, Yuan X, Johnson T, Abderrahmani A, Vollenweider P, Stirnadel H, Sundseth SS, Lai E, et al. Risk prediction of prevalent diabetes in a Swiss population using a weighted genetic score–the CoLaus Study. Diabetologia. 2009;52(4):600–8.

    CAS 
    Article 

    Google Scholar
     

  • Liu ZY, Wang ZD, Li LZ, Chu XF, Zhu YS, Shi JM, Xie XJ, Jin L, Wang Y, Wang XF. Association of CRP gene polymorphisms with CRP levels, frailty and co-morbidity in an elderly Chinese population: results from RuLAS. Age Ageing. 2016;45(3):360–5.

    Article 

    Google Scholar
     

  • Pan HY, Mi YY, Xu K, Zhang Z, Wu H, Zhang W, Yuan W, Shi L, Zhang LF, Zhu LJ, et al. Association of C-reactive protein (CRP) rs1205 and rs2808630 variants and risk of cancer. J Cell Physiol. 2020;235(11):8571-84.

  • Miller DT, Zee RY, Suk Danik J, Kozlowski P, Chasman DI, Lazarus R, Cook NR, Ridker PM, Kwiatkowski DJ. Association of common CRP gene variants with CRP levels and cardiovascular events. Ann Human Genet. 2005;69(Pt 6):623–38.

    CAS 
    Article 

    Google Scholar
     

  • Ulrich CM, Bigler J, Potter JD. Non-steroidal anti-inflammatory drugs for cancer prevention: promise, perils and pharmacogenetics. Nat Rev. 2006;6(2):130–40.

    CAS 
    Article 

    Google Scholar
     

  • Sheu WH, Wang WC, Wu KD, He CT, Hwu CM, Quertermous T, Hsieh WS, Lee WJ, Ting CT, Chen YI, et al. CRP-level-associated polymorphism rs1205 within the CRP gene is associated with 2-hour glucose level: The SAPPHIRe study. Scientific reports. 2017;7(1):7987.

    Article 

    Google Scholar
     

  • Hursting SD, Berger NA. Energy balance, host-related factors, and cancer progression. J Clin Oncol. 2010;28(26):4058–65.

    Article 

    Google Scholar
     

  • Fedirko V, Riboli E, Tjonneland A, Ferrari P, Olsen A, Bueno-de-Mesquita HB, van Duijnhoven FJ, Norat T, Jansen EH, Dahm CC, et al. Prediagnostic 25-hydroxyvitamin D, VDR and CASR polymorphisms, and survival in patients with colorectal cancer in western European ppulations. Cancer Epidemiol Biomarkers Prev. 2012;21(4):582–93.

    CAS 
    Article 

    Google Scholar
     

  • Dehghan A, Dupuis J, Barbalic M, Bis JC, Eiriksdottir G, Lu C, Pellikka N, Wallaschofski H, Kettunen J, Henneman P, et al. Meta-analysis of genome-wide association studies in > 80 000 subjects identifies multiple loci for C-reactive protein levels. Circulation. 2011;123(7):731–8.

    CAS 
    Article 

    Google Scholar
     

  • Austin PC, Lee DS, Fine JP. Introduction to the Analysis of Survival Data in the Presence of Competing Risks. Circulation. 2016;133(6):601–9.

    Article 

    Google Scholar
     

  • Mayeda ER, Glymour MM. The Obesity Paradox in Survival after Cancer Diagnosis: Tools for Evaluation of Potential Bias. Cancer Epidemiol Biomarkers Prev. 2017;26(1):17–20.

    Article 

    Google Scholar
     

  • Hernan MA, Hernandez-Diaz S, Robins JM. A structural approach to selection bias. Epidemiol. 2004;15(5):615–25.

    Article 

    Google Scholar
     

  • Banack HR, Kaufman JS. From bad to worse: collider stratification amplifies confounding bias in the “obesity paradox”. Eur J Epidemiol. 2015;30(10):1111–4.

    Article 

    Google Scholar
     

  • Rights and permissions

    Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.

    Disclaimer:

    This article is autogenerated using RSS feeds and has not been created or edited by OA JF.

    Click here for Source link (https://www.biomedcentral.com/)

    By admin